Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
World Journal of Urology
|
July 12, 2017
Implementation of minimally invasive percutaneous nephrolithotomy (MIP): comparison of the initial learning curve with the later on clinical routine in a tertiary centre
T Bergmann, T R W Herrmann, Th Schiller, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
|
May 14, 2026
Tailored contact brachytherapy for challenging facial basal cell carcinomas: clinical results of 3D printing technology implementation
Artur J Chyrek, Grzegorz Bielęda, Adam Kluska, et al.
Critical Reviews in Oncology/Hematology
|
August 31, 2015
Jump in the fire--heat shock proteins and their impact on ovarian cancer therapy
M B Stope, D Koensgen, M Burchardt, et al.
Journal of Contemporary Brachytherapy
|
May 22, 2023
The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy
Wojciech M Burchardt, Artur J Chyrek, Grzegorz M Bielęda, et al.
MLO: Medical Laboratory Observer
|
August 18, 2000
Bladder cancer markers. Current availability and the future standard of care
I S Sawczuk, T Burchardt, A Shabsigh, et al.
European Urology
|
February 26, 2003
Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications
M V Cronauer, W A Schulz, H-H Seifert, et al.
Cancer Research
|
December 20, 1999
Apoptotic conversion: evidence for exchange of genetic information between prostate cancer cells mediated by apoptosis
A de la Taille, M W Chen, M Burchardt, et al.
Der Urologe. Ausg. A
|
July 25, 2019
[Influence of culture and religion on the treatment of cancer patients]
J Fischer, M B Stope, D Gümbel, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
November 4, 2000
Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports
A de la Taille, O R Hayek, M Burchardt, et al.
Clinical Chemistry
|
May 5, 2000
Current concepts in biomarker technology for bladder cancers
M Burchardt, T Burchardt, A Shabsigh, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
World Journal of Urology
|
July 12, 2017
Implementation of minimally invasive percutaneous nephrolithotomy (MIP): comparison of the initial learning curve with the later on clinical routine in a tertiary centre
T Bergmann, T R W Herrmann, Th Schiller, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
|
May 14, 2026
Tailored contact brachytherapy for challenging facial basal cell carcinomas: clinical results of 3D printing technology implementation
Artur J Chyrek, Grzegorz Bielęda, Adam Kluska, et al.
Critical Reviews in Oncology/Hematology
|
August 31, 2015
Jump in the fire--heat shock proteins and their impact on ovarian cancer therapy
M B Stope, D Koensgen, M Burchardt, et al.
Journal of Contemporary Brachytherapy
|
May 22, 2023
The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy
Wojciech M Burchardt, Artur J Chyrek, Grzegorz M Bielęda, et al.
MLO: Medical Laboratory Observer
|
August 18, 2000
Bladder cancer markers. Current availability and the future standard of care
I S Sawczuk, T Burchardt, A Shabsigh, et al.
European Urology
|
February 26, 2003
Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications
M V Cronauer, W A Schulz, H-H Seifert, et al.
Cancer Research
|
December 20, 1999
Apoptotic conversion: evidence for exchange of genetic information between prostate cancer cells mediated by apoptosis
A de la Taille, M W Chen, M Burchardt, et al.
Der Urologe. Ausg. A
|
July 25, 2019
[Influence of culture and religion on the treatment of cancer patients]
J Fischer, M B Stope, D Gümbel, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
November 4, 2000
Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports
A de la Taille, O R Hayek, M Burchardt, et al.
Clinical Chemistry
|
May 5, 2000
Current concepts in biomarker technology for bladder cancers
M Burchardt, T Burchardt, A Shabsigh, et al.
Page
of 6